i2S Stock

Equities

ALI2S

FR0005854700

Computer Hardware

Market Closed - Euronext Paris 10:30:06 2024-04-26 am EDT 5-day change 1st Jan Change
7.1 EUR -2.74% Intraday chart for i2S 0.00% +22.41%
Sales 2022 16.71M 17.87M Sales 2023 17.52M 18.73M Capitalization 9.61M 10.28M
Net income 2022 4M 4.28M Net income 2023 - 0 EV / Sales 2022 0.53 x
Net cash position 2022 2.01M 2.14M Net Debt 2023 2.19M 2.34M EV / Sales 2023 0.67 x
P/E ratio 2022
2.49 x
P/E ratio 2023
10.8 x
Employees 72
Yield 2022
2.3%
Yield 2023
2.41%
Free-Float 91.38%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.74%
Current month+5.19%
1 month-3.40%
3 months+18.33%
6 months+36.54%
Current year+22.41%
More quotes
1 week
7.10
Extreme 7.1
7.40
1 month
6.70
Extreme 6.7
7.40
Current year
5.10
Extreme 5.1
7.40
1 year
4.84
Extreme 4.84
7.40
3 years
3.50
Extreme 3.5
7.40
5 years
2.76
Extreme 2.76
7.40
10 years
1.04
Extreme 1.04
7.40
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Founder - 78-12-31
Director of Finance/CFO - -
Members of the board TitleAgeSince
Founder - 78-12-31
Director/Board Member 69 17-06-25
Founder - 78-12-31
More insiders
Date Price Change Volume
24-04-26 7.1 -2.74% 119
24-04-25 7.3 +2.82% 2,238
24-04-24 7.1 0.00% 0
24-04-23 7.1 0.00% 0
24-04-22 7.1 0.00% 18

Real-time Euronext Paris, April 26, 2024 at 10:30 am EDT

More quotes
i2S specializes in design, creating, manufacturing and marketing of imaging systems and equipment. The activity is organized around 4 families of products: - industrial imaging and vision solutions (i2S - Vision): cameras, standard components for image acquisition and processing, and imaging software solutions for machine vision and robotics applications; - bound document digitization solutions (i2S - DigiBook): scanners and solutions for dematerializing books and document collections for libraries and archives; - specialized cameras and integrated vision solutions for medical and biomedical applications (i2S - Medcare); - underwater imaging solutions (i2S - Orphie). France accounts for 51.3% of net sales.
More about the company